temozolomide has been researched along with Pneumonia, Pneumocystis in 9 studies
Pneumonia, Pneumocystis: A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "High-grade glioma patients receiving concomitant chemoradiotherapy with temozolomide 75mg/m(2) during six to seven weeks or dose-dense temozolomide regimens especially in combination with chronic use of corticosteroids have a high risk for developing Pneumocystis jirovecii pneumonia." | 8.89 | Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas. ( Bleeker-Rovers, CP; De Vos, FY; Gijtenbeek, JM; van Herpen, CM, 2013) |
| "Temozolomide is utilized as a treatment for a variety of solid tumors and has been associated with the development of selective lymphopenia." | 7.74 | Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. ( Baden, LR; Kulke, MH; Michelini, A; Schwarzberg, AB; Sengupta, T; Stover, EH; Vincitore, M, 2007) |
| "Severe temozolomide-induced immunosuppression, exacerbated by corticosteroids, with profound T-cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma." | 7.73 | Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide. ( Bally, F; Christen, G; de Ribaupierre, S; Ganière, V; Guillou, L; Pica, A; Stupp, R, 2006) |
| "High-grade glioma patients receiving concomitant chemoradiotherapy with temozolomide 75mg/m(2) during six to seven weeks or dose-dense temozolomide regimens especially in combination with chronic use of corticosteroids have a high risk for developing Pneumocystis jirovecii pneumonia." | 4.89 | Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas. ( Bleeker-Rovers, CP; De Vos, FY; Gijtenbeek, JM; van Herpen, CM, 2013) |
| "Prophylaxis against Pneumocystis jiroveci pneumonia (PJP) is currently recommended for patients receiving chemoradiation with temozolomide for newly diagnosed glioblastoma multiforme." | 3.80 | Incidence of Pneumocystis jirovecii pneumonia after temozolomide for CNS malignancies without prophylaxis. ( Barnes, PD; Bubalo, J; Fu, R; Gahramanov, S; Lacy, C; Nasseri, M; Neuwelt, AJ; Neuwelt, EA; Nguyen, TM; Tyson, RM, 2014) |
| "Temozolomide is an oral alkylating agent recently approved for the treatment of glioblastoma multiforme." | 3.74 | Temozolomide-associated organizing pneumonitis. ( Aubrey, MC; Lim, KG; Limper, AH; Maldonado, F, 2007) |
| "Temozolomide is utilized as a treatment for a variety of solid tumors and has been associated with the development of selective lymphopenia." | 3.74 | Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. ( Baden, LR; Kulke, MH; Michelini, A; Schwarzberg, AB; Sengupta, T; Stover, EH; Vincitore, M, 2007) |
| "Severe temozolomide-induced immunosuppression, exacerbated by corticosteroids, with profound T-cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma." | 3.73 | Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide. ( Bally, F; Christen, G; de Ribaupierre, S; Ganière, V; Guillou, L; Pica, A; Stupp, R, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Climans, SA | 1 |
| Grunfeld, E | 1 |
| Mason, WP | 1 |
| Chan, KKW | 1 |
| Balzarini, L | 1 |
| Mancini, C | 1 |
| Marvisi, M | 1 |
| Neuwelt, AJ | 1 |
| Nguyen, TM | 1 |
| Fu, R | 1 |
| Bubalo, J | 1 |
| Tyson, RM | 1 |
| Lacy, C | 1 |
| Gahramanov, S | 1 |
| Nasseri, M | 1 |
| Barnes, PD | 1 |
| Neuwelt, EA | 1 |
| Gorospe Sarasúa, L | 1 |
| Ureña-Vacas, A | 1 |
| Muñoz Del Toro, JR | 1 |
| De Vos, FY | 1 |
| Gijtenbeek, JM | 1 |
| Bleeker-Rovers, CP | 1 |
| van Herpen, CM | 1 |
| Ganière, V | 1 |
| Christen, G | 1 |
| Bally, F | 1 |
| Guillou, L | 1 |
| Pica, A | 1 |
| de Ribaupierre, S | 1 |
| Stupp, R | 1 |
| Maldonado, F | 1 |
| Limper, AH | 1 |
| Lim, KG | 1 |
| Aubrey, MC | 1 |
| Schwarzberg, AB | 1 |
| Stover, EH | 1 |
| Sengupta, T | 1 |
| Michelini, A | 1 |
| Vincitore, M | 1 |
| Baden, LR | 1 |
| Kulke, MH | 1 |
| Yu, SK | 1 |
| Chalmers, AJ | 1 |
1 review available for temozolomide and Pneumonia, Pneumocystis
| Article | Year |
|---|---|
Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents, Alkylating; Dacarbazine; Gliom | 2013 |
8 other studies available for temozolomide and Pneumonia, Pneumocystis
| Article | Year |
|---|---|
Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy.
Topics: Anti-Bacterial Agents; Chemoradiotherapy; Humans; Pneumonia, Pneumocystis; Retrospective Studies; Te | 2022 |
A fatal case of acute interstitial pneumonia (AIP) in a woman affected by glioblastoma.
Topics: Aged; Antineoplastic Agents, Alkylating; Blood Gas Analysis; Brain Neoplasms; Bronchoalveolar Lavage | 2014 |
Incidence of Pneumocystis jirovecii pneumonia after temozolomide for CNS malignancies without prophylaxis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chil | 2014 |
Pneumocystis jirovecii pneumonia complicating the progress of a patient with glioblastoma multiforme receiving temozolomide.
Topics: Adrenal Cortex Hormones; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemothera | 2016 |
Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide.
Topics: Antineoplastic Agents, Alkylating; Brain Abscess; Brain Neoplasms; Dacarbazine; Glioblastoma; Humans | 2006 |
Temozolomide-associated organizing pneumonitis.
Topics: Aged, 80 and over; Antineoplastic Agents, Alkylating; Dacarbazine; Glioblastoma; Humans; Male; Pneum | 2007 |
Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Cytomegalovirus Infections; Dacarbazine; Female; Her | 2007 |
Patients receiving standard-dose temozolomide therapy are at risk of Pneumocystis carinii pneumonia.
Topics: Adrenal Cortex Hormones; Antibiotic Prophylaxis; Antineoplastic Agents, Alkylating; CD4 Lymphocyte C | 2007 |